Jacques Otten
Impact in
-
- Acute Lymphoblastic Leukemia research
-
- Lymphoma Diagnosis and Treatment
Papers in
-
- Acute Lymphoblastic Leukemia research 22
-
- Neuroblastoma Research and Treatments 2
- Neurofibromatosis and Schwannoma Cases 2
- Co-authors
- J. P. Lamagnere (2 shared papers)Thierry O. Philip (2 shared papers)J.C. Gentet (2 shared papers)Stefan Suciu (12 shared papers)Chantal Rodary (2 shared papers)Francois J. L. Pein (1 shared paper)Catherine Patte (1 shared paper)D Dufillot (1 shared paper)
- Journals
- Blood (8 papers)Leukemia (4 papers)European Journal of Cancer (3 papers)Archives of Disease in Childhood (2 papers)Journal of Pediatric Hematology/Oncology (2 papers)
- Partner nations
- BelgiumFranceNetherlands
In The Last Decade
Jacques Otten
46 papers receiving 1.7k citations
Peers
Comparison fields: 5 of 39
- Public Health, Environmental and Occupational Health 786
- Pathology and Forensic Medicine 193
- Hematology 136
- Neurology 135
- Immunology 55
Countries citing papers authored by Jacques Otten
This map shows the geographic impact of Jacques Otten's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jacques Otten with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jacques Otten more than expected).
Fields of papers citing papers by Jacques Otten
This network shows the impact of papers produced by Jacques Otten. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jacques Otten. The network helps show where Jacques Otten may publish in the future.
Co-authors
The 25 scholars most cited alongside Jacques Otten, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 47 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2012 | 248 | |
| 2 | 1991 | 244 | |
| 3 | 2000 | 177 | |
| 4 | 1998 | 121 | |
| 5 | 2010 | 111 | |
| 6 | The prognostic significance of CDKN2A, CDKN2B and MTAP inactivation in B-lineage acute lymphoblastic leukemia of childhood. Results of the EORTC studies 58881 and 58951. | 2006 | 89 |
| 7 | 1997 | 71 | |
| 8 | 1994 | 59 | |
| 9 | 2005 | 56 | |
| 10 | 2010 | 56 | |
| 11 | 2010 | 54 | |
| 12 | 1993 | 49 | |
| 13 | 2002 | 49 | |
| 14 | 2001 | 42 | |
| 15 | 1995 | 38 | |
| 16 | 1990 | 35 | |
| 17 | 1986 | 30 | |
| 18 | 1990 | 27 | |
| 19 | 2005 | 23 | |
| 20 | 1996 | 22 |
About Jacques Otten
Jacques Otten is a scholar working on Public Health, Environmental and Occupational Health, Neurology, Internal Medicine, Hematology and Pathology and Forensic Medicine, having authored 47 papers that have together received 1.8k indexed citations. Recurring topics across this work include Acute Lymphoblastic Leukemia research (22 papers), Acute Myeloid Leukemia Research (3 papers), Immunodeficiency and Autoimmune Disorders (3 papers), Venous Thromboembolism Diagnosis and Management (2 papers), Lymphoma Diagnosis and Treatment (2 papers), Neuroblastoma Research and Treatments (2 papers), Neurofibromatosis and Schwannoma Cases (2 papers) and Nausea and vomiting management (1 paper). The work is most often cited by research in Public Health, Environmental and Occupational Health (786 citations), Pathology and Forensic Medicine (193 citations), Hematology (136 citations), Neurology (135 citations) and Immunology (55 citations). Jacques Otten has collaborated with scholars based in Belgium, France and Netherlands. Frequent co-authors include J. P. Lamagnere, Thierry O. Philip, J.C. Gentet, Stefan Suciu, Chantal Rodary, Francois J. L. Pein, Catherine Patte, D Dufillot, H. Behrendt and J M Zucker. Their work appears in journals such as Blood, Leukemia, European Journal of Cancer, Archives of Disease in Childhood and Journal of Pediatric Hematology/Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.